38 related articles for article (PubMed ID: 2940298)
21. Natural cytotoxic cell-specific cytotoxic factor produced by IL-3-dependent basophilic/mast cells. Relationship to TNF.
Richards AL; Okuno T; Takagaki Y; Djeu JY
J Immunol; 1988 Nov; 141(9):3061-6. PubMed ID: 3262677
[TBL] [Abstract][Full Text] [Related]
22. Gene expression and production of tumour necrosis factor by a rat basophilic leukaemia cell line (RBL-2H3) with IgE receptor triggering.
Ohno I; Tanno Y; Yamauchi K; Takishima T
Immunology; 1990 May; 70(1):88-93. PubMed ID: 2141321
[TBL] [Abstract][Full Text] [Related]
23. Natural cytotoxic activity in a cloned natural killer cell line is mediated by tumor necrosis factor.
Richards AL; Dennert G; Pluznik DH; Takagaki Y; Djeu JY
Nat Immun Cell Growth Regul; 1989; 8(2):76-88. PubMed ID: 2761550
[TBL] [Abstract][Full Text] [Related]
24. The fate of IgE bound to rat basophilic leukemia cells. III. Relationship between antigen-induced endocytosis and serotonin release.
Furuichi K; Rivera J; Isersky C
J Immunol; 1984 Sep; 133(3):1513-20. PubMed ID: 6205083
[TBL] [Abstract][Full Text] [Related]
25. Interaction of monoclonal antibodies with the IgE-receptor on rat mast cells and rat basophilic leukemia (RBL) cells.
Micklefield G; König W; Pfeiffer P; Bohn A
Agents Actions; 1986 Mar; 17(5-6):418-26. PubMed ID: 2422899
[TBL] [Abstract][Full Text] [Related]
26. Natural cytotoxic (NC) cell activity in basophilic cells: release of NC-specific cytotoxic factor by IgE receptor triggering.
Okuno T; Takagaki Y; Pluznik DH; Djeu JY
J Immunol; 1986 Jun; 136(12):4652-8. PubMed ID: 2940298
[TBL] [Abstract][Full Text] [Related]
27. Review: Diagnostic and therapeutic applications of rat basophilic leukemia cells.
Rashid A; Sadroddiny E; Ye HT; Vratimos A; Sabban S; Carey E; Helm B
Mol Immunol; 2012 Oct; 52(3-4):224-8. PubMed ID: 22750069
[TBL] [Abstract][Full Text] [Related]
28. Antisera to mast cells and the receptor for IgE.
Froese A
Immunol Commun; 1976; 5(5):437-53. PubMed ID: 786866
[TBL] [Abstract][Full Text] [Related]
29. The role of immunoreceptors.
Stanworth DR
Arch Toxicol Suppl; 1985; 8():21-32. PubMed ID: 3913400
[TBL] [Abstract][Full Text] [Related]
30. [Immune complexes and effector cell activation (author's transl)].
Capron A; Dessaint JP; Pestel J
Ann Immunol (Paris); 1982; 133C(2):229-38. PubMed ID: 6214205
[TBL] [Abstract][Full Text] [Related]
31. Application of synthetic peptides representative of immunoglobulin sequences to the delineation of receptor binding and signalling processes.
Stanworth DR
Mol Immunol; 1982 Oct; 19(10):1245-54. PubMed ID: 6184612
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
